15.97

6.61% -1.13

After Hours: 15.97

Ceribell Inc (CBLL)

Overview News Price History Discussions Forecast

Ceribell Inc stock is traded at $15.97, with a volume of 468.17K. It is down -6.61% in the last 24 hours and down -16.95% over the past month. CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Previous Close:

$17.10

Open:

$17.79

24h Volume:

468.17K

Relative Volume:

1.71

Market Cap:

$588.08M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-2.14%

1M Performance:

-16.95%

6M Performance:

-43.51%

1Y Performance:

+0.00%

1-Day Range:

$15.55

$17.79

1-Week Range:

$15.20

$17.79

52-Week Range:

$10.01

$32.75

Ceribell Inc Stock (CBLL) Company Profile

Name

Ceribell Inc

Sector

Healthcare (1153)

Industry

Medical Devices (157)

Phone

(800) 436-0826

Address

360 N. PASTORIA AVENUE, SUNNYVALE

Employee

281

Twitter

Next Earnings Date

Latest SEC Filings

CBLL's Discussions on Twitter

Compare CBLL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CBLL Ceribell Inc	15.97	588.08M	0	0	0	0.00
ABT Abbott Laboratories	133.24	231.09B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	102.86	155.24B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	380.92	144.54B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	83.48	108.82B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	73.68	44.31B	5.54B	4.18B	623.10M	7.00

Ceribell Inc Stock (CBLL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-04-25	Initiated	Ladenburg Thalmann	Buy
Nov-05-24	Initiated	BofA Securities	Buy
Nov-05-24	Initiated	Canaccord Genuity	Buy
Nov-05-24	Initiated	JP Morgan	Overweight
Nov-05-24	Initiated	TD Cowen	Buy
Nov-05-24	Initiated	William Blair	Outperform

View All

Ceribell Inc Stock (CBLL) Latest News

08:40 AM

Wells Fargo & Company MN Takes $167,000 Position in CeriBell (NASDAQ:CBLL) - Defense World

08:40 AM

May 09, 2025

Ceribell, Inc. Earnings Call Highlights Growth and Challenges - TipRanks

May 09, 2025

AI in Clinics and Hospitals, Along with FDA Steps Signal Opportunity for Early Mover Advantages - The Globe and Mail

May 09, 2025

Ceribell, Inc.: A Strong Buy Amidst Promising Growth and Robust Fundamentals - TipRanks

May 09, 2025

CeriBell revenue jumps 42% to USD 20.5 million in Q1 2025 - Medical Buyer

May 09, 2025

MetLife Investment Management LLC Acquires Shares of 7,749 CeriBell (NASDAQ:CBLL) - Defense World

May 09, 2025

Barclays PLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World

May 09, 2025

Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% - Investing.com

May 09, 2025

Ceribell, Inc. Receives Buy Rating Amid Strong Revenue Growth and Financial Performance - TipRanks

May 09, 2025

May 08, 2025

CeriBell Inc expected to post a loss of 42 cents a shareEarnings Preview - TradingView

May 06, 2025

May 05, 2025

Invesco Ltd. Takes $252,000 Position in CeriBell (NASDAQ:CBLL) - Defense World

May 05, 2025

May 02, 2025

Legal & General Group Plc Takes Position in CeriBell (NASDAQ:CBLL) - Defense World

May 02, 2025

Head-To-Head Survey: CeriBell (NASDAQ:CBLL) and ADM Tronics Unlimited (OTCMKTS:ADMT) - Defense World

May 02, 2025

Analysts Set CeriBell (NASDAQ:CBLL) PT at $32.50 - Defense World

May 02, 2025

May 01, 2025

Ceribell Earns FedRAMP High Authorization for Its Point-of-Care EEG - Medical Product Outsourcing

May 01, 2025

41,900 Shares in CeriBell (NASDAQ:CBLL) Acquired by Renaissance Technologies LLC - Defense World

May 01, 2025

Apr 30, 2025

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference - The Manila Times

Apr 30, 2025

CeriBell, Inc. to Present at Bank of America Securities 2025 Health Care Conference on May 14, 2025 - Nasdaq

Apr 30, 2025

CeriBell Gets FedRAMP High Authorization for EEG System - marketscreener.com

Apr 30, 2025

Ceribell Says EEG System Receives FedRAMP High Authorization - marketscreener.com

Apr 30, 2025

Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems - The Manila Times

Apr 30, 2025

Ceribell Receives FedRAMP® High Authorization, Expanding - GlobeNewswire

Apr 30, 2025

Ceribell announces EEG system received full RedRAMP High authorization - TipRanks

Apr 30, 2025

Apr 29, 2025

JPMorgan Chase & Co. Takes $880,000 Position in CeriBell (NASDAQ:CBLL) - Defense World

Apr 29, 2025

Apr 26, 2025

Geode Capital Management LLC Makes New $6.65 Million Investment in CeriBell (NASDAQ:CBLL) - Defense World

Apr 26, 2025

Apr 24, 2025

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times

Apr 24, 2025

CeriBell, Inc. to Release Q1 2025 Financial Results and Host Conference Call on May 8, 2025 - Nasdaq

Apr 24, 2025

CBLL Stock Sees Surge of Approximately 3.50% in Last Five Days - knoxdaily.com

Apr 24, 2025